Interim FDG PET Scans in Lymphoma: SUV Measurement Error May Impair qPET Methodology

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-014-2879-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Interim FDG-PET/CT in Hodgkin Lymphoma: What Are We Actually Looking At?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2018English

Fact Sheet About Interim and End-Of-Treatment 18 F-FDG PET/CT in Lymphoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

Reply: Fact Sheet About Interim and End-Of-Treatment 18 F-FDG PET/CT in Lymphoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Quantitative Assessment of Interim PET in Hodgkin Lymphoma: An Evaluation of the qPET Method in Adult Patients in the RAPID Trial

PLoS ONE
Multidisciplinary
2020English

FDG-PET Scan in Lymphoma: Silver Anniversary

Clinical and Translational Imaging
Nuclear MedicineRadiologyImaging
2015English

Hodgkin Lymphoma: Is There Really a Need for Interim and End-Of-Treatment FDG-PET Evaluations?

British Journal of Haematology
Hematology
2016English

Automated Measurement of Uptake in Cerebellum, Liver, and Aortic Arch in Full-Body FDG PET/CT Scans

Medical Physics
MedicineNuclear MedicineRadiologyImagingBiophysics
2012English

A Score Combining SUV Peak of the Primary Tumor Computed on Pretreatment FDG-PET Scans and Neutrophilia Predicts Outcome in Locally Advanced Cervical Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy